Literature DB >> 3871167

Adverse Drug Reaction Reporting Program of the Ontario Medical Association: the first 3 years.

C W Gowdey, M Brennan.   

Abstract

This paper describes the Adverse Drug Reaction Reporting Program developed and operated by the Committee on Drugs and Pharmaco-therapy of the Ontario Medical Association. Analyses were done to demonstrate some of the trends derived from the reports. Some of the clinical observations based on the reports, which are published quarterly and circulated to physicians and to pharmacy, nursing and hospital organizations, are also reviewed.

Mesh：

Substances：

Year:  1985        PMID： 3871167      PMCID： PMC1346498     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


  14 in total

1.  Adverse drug reactions. A critical review.

Authors:  F E Karch; L Lasagna
Journal:  JAMA       Date:  1975-12-22       Impact factor: 56.272

2.  Adverse drug reactions and death. A review of 827 cases.

Authors:  N S Irey
Journal:  JAMA       Date:  1976-08-09       Impact factor: 56.272

3.  Drug evaluation after marketing.

Authors:  D Slone; S Shapiro; O S Miettinen; W D Finkle; P D Stolley
Journal:  Ann Intern Med       Date:  1979-02       Impact factor: 25.391

4.  Adverse drug reactions: uncommon or unrecognized?

Authors:  E M Sellers
Journal:  Can Med Assoc J       Date:  1979-05-19       Impact factor: 8.262

5.  Editorial: Fatal reactions to drug therapy.

Authors:  J Koch-Weser
Journal:  N Engl J Med       Date:  1974-08-08       Impact factor: 91.245

6.  Adverse effects of NSAIDs on renal function.

Authors:  A L Linton
Journal:  Can Med Assoc J       Date:  1984-08-01       Impact factor: 8.262

7.  Postmarketing surveillance of adverse drug reactions in general practice. I: search for new methods.

Authors:  W H Inman
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-04

8.  Discovery of adverse drug reactions. A comparison of selected phase IV studies with spontaneous reporting methods.

Authors:  A C Rossi; D E Knapp; C Anello; R T O'Neill; C F Graham; P S Mendelis; G R Stanley
Journal:  JAMA       Date:  1983 Apr 22-29       Impact factor: 56.272

9.  When is a clinical event an adverse drug reaction?

Authors:  M R Achong
Journal:  Can Med Assoc J       Date:  1978-12-09       Impact factor: 8.262

10.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875
View more
  7 in total

1.  Prescribing to the elderly: a review of the english language canadian literature.

Authors:  J Lexchin
Journal:  Can Fam Physician       Date:  1989-08       Impact factor: 3.275

2.  Adverse Drug Reactions: Review of the Canadian literature.

Authors:  J Lexchin
Journal:  Can Fam Physician       Date:  1991-01       Impact factor: 3.275

3.  A Review of Fatalities Reported as Associated with NSAID Treatment in Ontario.

Authors:  C W Gowdey; M Brennan
Journal:  Can Fam Physician       Date:  1986-09       Impact factor: 3.275

4.  Measuring birth defects and handicapping disorders in the population: the British Columbia Health Surveillance Registry.

Authors:  P A Baird
Journal:  CMAJ       Date:  1987-01-15       Impact factor: 8.262

5.  Postmarketing surveillance of adverse drug reactions: problems and solutions.

Authors:  F M Lortie
Journal:  CMAJ       Date:  1986-07-01       Impact factor: 8.262

6.  Potentially undesirable prescribing and drug use among the elderly. Measurable and remediable.

Authors:  J A Bloom; J W Frank; M S Shafir; P Martiquet
Journal:  Can Fam Physician       Date:  1993-11       Impact factor: 3.275

7.  Drug-Related Deaths in China: An Analysis of a Spontaneous Reporting System.

Authors:  Haona Li; Jianxiong Deng; Peiming Yu; Xuequn Ren
Journal:  Front Pharmacol       Date:  2022-02-25       Impact factor: 5.810
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.